{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:12:36Z","timestamp":1795111956478,"version":"4.10.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer incidence increases markedly after midlife, coinciding with age-related hormonal decline and alterations in antioxidant defense mechanisms. This study investigated age-specific associations between endogenous antioxidant markers (total bilirubin, albumin, and uric acid) and prostate cancer risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were derived from the Korean Cancer Prevention Study-II (KCPS-II), and a total of 83,371 men were included after excluding individuals with a history of cancer or missing key variables at baseline. Participants were categorized into four age groups:\u2009&lt;\u200945, 45\u201355,\u2009&gt;\u200955, and\u2009&gt;\u200965\u00a0years. During a mean follow-up of 13.5\u00a0years, 705 incident cases of prostate cancer (ICD-10: C61) were identified. Hazard ratios (HRs) and 95% confidence intervals (CIs) for prostate cancer per 1-standard deviation (SD) increase in each antioxidant marker were estimated using Cox proportional hazards models. Quartile and trend analyses were also performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Total bilirubin showed a statistically significant negative association with prostate cancer risk in men aged 45\u201355\u00a0years (HR: 0.86, 95% CI: 0.75\u20130.98,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0208), while a significant positive association was observed in men over 65\u00a0years (HR: 1.21, 95% CI: 1.02\u20131.43,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0285). Albumin was not significantly associated with prostate cancer risk in most age groups, but a significant positive association was found in men under 45\u00a0years (HR: 1.41, 95% CI: 1.07\u20131.86,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0152). Uric acid showed a consistent positive association with prostate cancer risk in the overall population (HR: 1.13, 95% CI: 1.06\u20131.21,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0003), and in men aged\u2009&lt;\u200945\u00a0years (HR: 1.15, 95% CI: 1.02\u20131.30,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0241),\u2009&gt;\u200955\u00a0years (HR: 1.20, 95% CI: 1.08\u20131.32,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0005), and\u2009&gt;\u200965\u00a0years (HR: 1.20, 95% CI: 1.04\u20131.38,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0121).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Total bilirubin was negatively associated with prostate cancer risk during the andropause period (ages 45\u201355), but this association reversed with increasing age. Uric acid consistently showed a positive association with prostate cancer risk across all age groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-025-02029-6","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:33:22Z","timestamp":1766536402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prostate cancer risk and antioxidant biomarkers: the age-dependent reversal of bilirubin\u2019s role"],"prefix":"10.1186","volume":"26","author":[{"given":"Jong Won","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Woong","family":"Sull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thien","family":"Minh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ha","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"3","key":"2029_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2029_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2029_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/01485019808987931","volume":"40","author":"K Tserotas","year":"1998","unstructured":"Tserotas K, Merino G. Andropause and the aging male. Arch Androl. 1998;40(2):87\u201393. https:\/\/doi.org\/10.3109\/01485019808987931.","journal-title":"Arch Androl"},{"key":"2029_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101490","volume":"31","author":"D Cruz-Topete","year":"2020","unstructured":"Cruz-Topete D, Dominic P, Stokes KY. Uncovering sex-specific mechanisms of action of testosterone and redox balance. Redox Biol. 2020;31:101490. https:\/\/doi.org\/10.1016\/j.redox.2020.101490.","journal-title":"Redox Biol"},{"issue":"11","key":"2029_CR5","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1089\/ars.2007.1712","volume":"9","author":"A Prudova","year":"2007","unstructured":"Prudova A, Albin M, Bauman Z, Lin A, Vitvitsky V, Banerjee R. Testosterone regulation of homocysteine metabolism modulates redox status in human prostate cancer cells. Antioxid Redox Signal. 2007;9(11):1875\u201381. https:\/\/doi.org\/10.1089\/ars.2007.1712.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"2029_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1134\/S0006297922050030","volume":"87","author":"EV Kalinina","year":"2022","unstructured":"Kalinina EV, Gavriliuk LA, Pokrovsky VS. Oxidative stress and redox-dependent signaling in prostate cancer. Biochem Mosc. 2022;87(5):413\u201324. https:\/\/doi.org\/10.1134\/S0006297922050030.","journal-title":"Biochem Mosc"},{"issue":"2","key":"2029_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2008.12.011","volume":"282","author":"L Khandrika","year":"2009","unstructured":"Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Cancer Lett. 2009;282(2):125\u201336. https:\/\/doi.org\/10.1016\/j.canlet.2008.12.011.","journal-title":"Cancer Lett"},{"issue":"3","key":"2029_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/pcan.2013.13","volume":"16","author":"A Paschos","year":"2013","unstructured":"Paschos A, Pandya R, Duivenvoorden WC, Pinthus JH. Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics. Prostate Cancer Prostatic Dis. 2013;16(3):217\u201325. https:\/\/doi.org\/10.1038\/pcan.2013.13.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2029_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.freeradbiomed.2013.02.009","volume":"60","author":"A Rebillard","year":"2013","unstructured":"Rebillard A, Lefeuvre-Orfila L, Gueritat J, Cillard J. Prostate cancer and physical activity: adaptive response to oxidative stress. Free Radic Biol Med. 2013;60:115\u201324. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.02.009.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"2029_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/CEJ.0b013e32834a8002","volume":"21","author":"G Gupta-Elera","year":"2012","unstructured":"Gupta-Elera G, Garrett AR, Robison RA, O\u2019Neill KL. The role of oxidative stress in prostate cancer. Eur J Cancer Prev. 2012;21(2):155\u201362. https:\/\/doi.org\/10.1097\/CEJ.0b013e32834a8002.","journal-title":"Eur J Cancer Prev"},{"issue":"4792","key":"2029_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.3029864","volume":"235","author":"R Stocker","year":"1987","unstructured":"Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235(4792):1043\u20136. https:\/\/doi.org\/10.1126\/science.3029864.","journal-title":"Science"},{"issue":"13","key":"2029_CR12","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","volume":"582","author":"M Roche","year":"2008","unstructured":"Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783\u20137. https:\/\/doi.org\/10.1016\/j.febslet.2008.04.057.","journal-title":"FEBS Lett"},{"issue":"6","key":"2029_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/15257770802138558","volume":"27","author":"YY Sautin","year":"2008","unstructured":"Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008;27(6):608\u201319. https:\/\/doi.org\/10.1080\/15257770802138558.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"1","key":"2029_CR14","doi-asserted-by":"publisher","first-page":"13224","DOI":"10.1038\/s41598-021-92442-2","volume":"11","author":"T Inoguchi","year":"2021","unstructured":"Inoguchi T, Nohara Y, Nojiri C, Nakashima N. Association of serum bilirubin levels with risk of cancer development and total death. Sci Rep. 2021;11(1):13224. https:\/\/doi.org\/10.1038\/s41598-021-92442-2.","journal-title":"Sci Rep"},{"issue":"10","key":"2029_CR15","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/bjc.2017.313","volume":"117","author":"T K\u00fchn","year":"2017","unstructured":"K\u00fchn T, Sookthai D, Graf ME, Sch\u00fcbel R, Freisling H, Johnson T, et al. Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study. Br J Cancer. 2017;117(10):1572\u20139. https:\/\/doi.org\/10.1038\/bjc.2017.313.","journal-title":"Br J Cancer"},{"key":"2029_CR16","doi-asserted-by":"publisher","first-page":"1354235","DOI":"10.3389\/fonc.2024.1354235","volume":"14","author":"Y Yan","year":"2024","unstructured":"Yan Y, Lin H, He Z, Wang L. Serum uric acid and prostate cancer: findings from the NHANES (2007\u20132020). Front Oncol. 2024;14:1354235. https:\/\/doi.org\/10.3389\/fonc.2024.1354235.","journal-title":"Front Oncol"},{"issue":"3","key":"2029_CR17","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00394-022-03076-7","volume":"62","author":"Y Deng","year":"2023","unstructured":"Deng Y, Huang J, Wong MCS. Association between serum uric acid and prostate cancer risk in East Asian populations: a Mendelian randomization study. Eur J Nutr. 2023;62(3):1323\u20139. https:\/\/doi.org\/10.1007\/s00394-022-03076-7.","journal-title":"Eur J Nutr"},{"issue":"5","key":"2029_CR18","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.21037\/tcr-24-46","volume":"13","author":"W Yan","year":"2024","unstructured":"Yan W, Xiang P, Liu D, Zheng Y, Ping H. Association between the serum uric acid levels and prostate cancer: evidence from National Health and Nutrition Examination Survey (NHANES) 1999\u20132010. Transl Cancer Res. 2024;13(5):2308\u201314. https:\/\/doi.org\/10.21037\/tcr-24-46.","journal-title":"Transl Cancer Res"},{"key":"2029_CR19","doi-asserted-by":"publisher","unstructured":"Y.H. Jee, J. Emberson, K.J. Jung, S.J. Lee, S. Lee, J.H. Back, S. Hong, H. Kimm, P. Sherliker, S.H. Jee, S. Lewington, Cohort Profile: the Korean Cancer Prevention Study-II (KCPS-II) Biobank. Int J Epidemiol. 2018; 47(2): 385\u2013386f, https:\/\/doi.org\/10.1093\/ije\/dyx226.","DOI":"10.1093\/ije\/dyx226"},{"issue":"2","key":"2029_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41391-023-00667-1","volume":"27","author":"Y Liadi","year":"2024","unstructured":"Liadi Y, Campbell T, Dike P, Harlemon M, Elliott B, Odero-Marah V. Prostate cancer metastasis and health disparities: a systematic review. Prostate Cancer Prostatic Dis. 2024;27(2):183\u201391. https:\/\/doi.org\/10.1038\/s41391-023-00667-1.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"2029_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.urolonc.2012.07.012","volume":"32","author":"C De Nunzio","year":"2014","unstructured":"De Nunzio C, Albisinni S, Presicce F, Lombardo R, Cancrini F, Tubaro A. Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort. Urol Oncol. 2014;32(2):80\u20134. https:\/\/doi.org\/10.1016\/j.urolonc.2012.07.012.","journal-title":"Urol Oncol"},{"issue":"9","key":"2029_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3349\/ymj.2021.62.9.792","volume":"62","author":"YR Kim","year":"2021","unstructured":"Kim YR, Choi CK, Lee YH, Choi SW, Kim HY, Shin MH, et al. Association between albumin, total bilirubin, and uric acid serum levels and the risk of cancer: a prospective study in a Korean population. Yonsei Med J. 2021;62(9):792\u20138. https:\/\/doi.org\/10.3349\/ymj.2021.62.9.792.","journal-title":"Yonsei Med J"},{"issue":"4","key":"2029_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040936","volume":"14","author":"A Cicione","year":"2022","unstructured":"Cicione A, Brassetti A, Lombardo R, Franco A, Turchi B, D\u2019Annunzio S, et al. Metabolic syndrome and physical inactivity may be shared etiological agents of prostate cancer and coronary heart diseases. Cancers (Basel). 2022;14(4):936. https:\/\/doi.org\/10.3390\/cancers14040936.","journal-title":"Cancers (Basel)"},{"issue":"32","key":"2029_CR24","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32):4145\u201351. https:\/\/doi.org\/10.2174\/138161205774913255.","journal-title":"Curr Pharm Des"},{"issue":"16","key":"2029_CR25","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1073\/pnas.84.16.5918","volume":"84","author":"R Stocker","year":"1987","unstructured":"Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA. 1987;84(16):5918\u201322. https:\/\/doi.org\/10.1073\/pnas.84.16.5918.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2029_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1124\/mol.104.002832","volume":"66","author":"J Kapitulnik","year":"2004","unstructured":"Kapitulnik J. Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol. 2004;66(4):773\u20139. https:\/\/doi.org\/10.1124\/mol.104.002832.","journal-title":"Mol Pharmacol"},{"key":"2029_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fphar.2012.00055","volume":"3","author":"L V\u00edtek","year":"2012","unstructured":"V\u00edtek L. The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Front Pharmacol. 2012;3:55. https:\/\/doi.org\/10.3389\/fphar.2012.00055.","journal-title":"Front Pharmacol"},{"key":"2029_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2024.102727","volume":"85","author":"JW Shin","year":"2024","unstructured":"Shin JW, Kim N, Nguyen TM, Chapagain DD, Jee SH. Serum bilirubin subgroups and cancer risk: Insights with a focus on lung cancer. Cancer Epidemiol. 2024;85:102727. https:\/\/doi.org\/10.1016\/j.canep.2024.102727.","journal-title":"Cancer Epidemiol"},{"issue":"11","key":"2029_CR29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/healthcare13111321","volume":"13","author":"JW Shin","year":"2025","unstructured":"Shin JW, Nguyen TM, Jee SH. Sex-specific associations of total bilirubin, ALBI, and PALBI with lung cancer risk: Interactions with smoking and alcohol. Healthcare (Basel). 2025;13(11):1321. https:\/\/doi.org\/10.3390\/healthcare13111321.","journal-title":"Healthcare (Basel)"},{"issue":"2","key":"2029_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1210\/er.2002-0032","volume":"25","author":"CA Heinlein","year":"2004","unstructured":"Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev. 2004;25(2):276\u2013308. https:\/\/doi.org\/10.1210\/er.2002-0032.","journal-title":"Endocr Rev"},{"issue":"3","key":"2029_CR31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/BF03347072","volume":"34","author":"G Corona","year":"2011","unstructured":"Corona G, Baldi E, Maggi M. Androgen regulation of prostate cancer: where are we now? J Endocrinol Invest. 2011;34(3):232\u201343. https:\/\/doi.org\/10.1007\/BF03347072.","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"2029_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11934-018-0812-1","volume":"19","author":"KM Rodriguez","year":"2018","unstructured":"Rodriguez KM, Pastuszak AW, Khera M. The role of testosterone therapy in the setting of prostate cancer. Curr Urol Rep. 2018;19(8):67. https:\/\/doi.org\/10.1007\/s11934-018-0812-1.","journal-title":"Curr Urol Rep"},{"issue":"2","key":"2029_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ucl.2016.01.013","volume":"43","author":"JP Alukal","year":"2016","unstructured":"Alukal JP, Lepor H. Testosterone deficiency and the prostate. Urol Clin North Am. 2016;43(2):203\u20138. https:\/\/doi.org\/10.1016\/j.ucl.2016.01.013.","journal-title":"Urol Clin North Am"},{"issue":"12","key":"2029_CR34","doi-asserted-by":"publisher","first-page":"16229","DOI":"10.18632\/aging.203153","volume":"13","author":"W Yan","year":"2021","unstructured":"Yan W, Zhang T, Kang Y, Zhang G, Ji X, Feng X, et al. Testosterone ameliorates age-related brain mitochondrial dysfunction. Aging (Albany NY). 2021;13(12):16229\u201347. https:\/\/doi.org\/10.18632\/aging.203153.","journal-title":"Aging (Albany NY)"},{"issue":"Suppl_1","key":"2029_CR35","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab048.615","volume":"5","author":"A Visaria","year":"2021","unstructured":"Visaria A, Raju P, James J, Islam S, Khangura KK, Amanullah A, et al. Total testosterone confounds the association between total bilirubin and dyslipidemia. J Endocr Soc. 2021;5(Suppl_1):A302. https:\/\/doi.org\/10.1210\/jendso\/bvab048.615.","journal-title":"J Endocr Soc"},{"issue":"1","key":"2029_CR36","doi-asserted-by":"publisher","first-page":"8026","DOI":"10.1038\/s41598-021-87220-z","volume":"11","author":"HM Park","year":"2021","unstructured":"Park HM, Kim H, Lee HS, Lee YJ. Inverse association between serum bilirubin level and testosterone deficiency in middle-aged and older men. Sci Rep. 2021;11(1):8026. https:\/\/doi.org\/10.1038\/s41598-021-87220-z.","journal-title":"Sci Rep"},{"issue":"1","key":"2029_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12902-024-01651-z","volume":"24","author":"C Ling","year":"2024","unstructured":"Ling C, Liu Y, Yao M, Tian L. Positive association between serum bilirubin within the physiological range and serum testosterone levels. BMC Endocr Disord. 2024;24(1):119. https:\/\/doi.org\/10.1186\/s12902-024-01651-z.","journal-title":"BMC Endocr Disord"},{"key":"2029_CR38","doi-asserted-by":"publisher","unstructured":"Guerra Ruiz, A. R., Crespo, J., L\u00f3pez Mart\u00ednez, R. M., Iruzubieta, P., Casals Mercadal, G., Lalana Garc\u00e9s, M., & Morales Ruiz, M. (2021). Measurement and clinical usefulness of bilirubin in liver disease. Advances in Laboratory Medicine, 2(3):352\u2013372. https:\/\/doi.org\/10.1515\/almed-2021-0047","DOI":"10.1515\/almed-2021-0047"},{"key":"2029_CR39","doi-asserted-by":"publisher","unstructured":"Jee, Y.H., Wang, Y., Jung, K.J. et al. Genome-wide association studies in a large Korean cohort identify quantitative trait loci for 36 traits and illuminate their genetic architectures. Nat Commun 16, 4935 (2025). https:\/\/doi.org\/10.1038\/s41467-025-59950-5","DOI":"10.1038\/s41467-025-59950-5"},{"key":"2029_CR40","doi-asserted-by":"publisher","unstructured":"Shin JW, Sull JW, Minh NT, Jee SH. Bilirubin Metabolism and Thyroid Cancer: Insights from ALBI and PALBI Indices. Biomolecules. 2025;15(7):1042. https:\/\/doi.org\/10.3390\/biom15071042","DOI":"10.3390\/biom15071042"},{"key":"2029_CR41","doi-asserted-by":"publisher","unstructured":"Shin J-W, Nguyen T-M, Jee S-H. Association Between Creatinine and Lung Cancer Risk in Men Smokers: A Comparative Analysis with Antioxidant Biomarkers from the KCPS-II Cohort. Antioxidants. 2025; 14(5):584. https:\/\/doi.org\/10.3390\/antiox14050584","DOI":"10.3390\/antiox14050584"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-02029-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-02029-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-02029-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:30:48Z","timestamp":1769517048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-025-02029-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2029"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-02029-6","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Institutional Review Board of Severance Hospital (approval number: 4\u20132011-0277). The requirement for informed consent was waived as the study used anonymized retrospective data from a cohort database. All procedures involving human participants were performed in accordance with the Declaration of Helsinki, the institutional guidelines, and other relevant regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}